Google
Trusted Resources: News & Events
Latest announcements and gatherings
Clinical Trials: The Patient Experience
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a public virtual workshop on Thursday, April 13, from 11:00 a.m. – 3:00 p.m. ET.
The workshop, Clinical Trials: The Patient Experience, will feature a panel of rare disease patients, caregivers, and advocates who will share their experiences with gene therapy clinical trials. Through participation in clinical trials, patients can help advance the science of gene therapy and further the development of rare disease treatments.
+myBinderRelated Content
-
Fear, Anger, SCD and #BLACKLIVESMATTERJune 10, 2020 at 6pm Eastern Time Sessi...
-
La Jolla Pharmaceutical company announces initiation of pivotal clinical study of LJPC-401 in patients with beta tha...La Jolla Pharmaceutical company today an...
-
Acute Chest Syndrome in Children with Sickle Cell DiseaseAcute chest syndrome (ACS) is a frequent...
-
2019 Tackle Sickle Cell Casino NightTwin brothers and New England Patriots s...
-
Children’s Hospital of The King’s Daughters Sickle Cell ProgramChildren's Hospital of The King's Daught...
-
Mona Robbins, PhDDr. Mona Robbins is an Associate Profess...
-
The 14th Annual Sickle Cell Disease Research & Educational Symposium and 43rd National Sickle Cell Disease Scie...The Symposium is an exciting three-day m...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.